Gyeongbuk, South Korea

Sehwan Yang



 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Sehwan Yang: Innovator in Immunoglobulin Fusion Proteins

Introduction

Sehwan Yang is a prominent inventor based in Gyeongbuk, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of immunoglobulin fusion proteins. With a total of five patents to his name, Yang's work has the potential to impact various therapeutic applications.

Latest Patents

Yang's latest patents include innovative fusion proteins that comprise a biologically active molecule linked to an immunoglobulin (Ig) Fc domain. One of his notable inventions is the chimeric immunoglobulin fusion proteins, which utilize a hybrid human Fc domain derived from IgG1, IgG2, or IgG4, or a combination of IgG4 and IgD. This hybrid Fc domain serves as an effective carrier for biologically active molecules. Another significant patent involves G-CSF immunoglobulin fusion proteins, which share similar characteristics and applications as his chimeric immunoglobulin fusion proteins.

Career Highlights

Throughout his career, Sehwan Yang has worked with esteemed organizations such as the Postech Academy-Industry Foundation and Genexine, Inc. His experience in these institutions has allowed him to refine his expertise in the field of immunology and biotechnology.

Collaborations

Yang has collaborated with various professionals in his field, including his coworker Young Chul Sung. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Sehwan Yang is a notable inventor whose work in immunoglobulin fusion proteins showcases his innovative spirit and dedication to advancing biotechnology. His contributions have the potential to lead to significant advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…